| 标题 |
专利、报告等 Abstract PS4-06-17: First clinical data of DB-1310 (HER3-targeted antibody-drug-conjugate), in patients with pretreated hormone receptor-positive/HER2-negative breast cancer: efficacy and safety data from a phase 1/2a trial |
| 备注 |
2025 SABCS poster
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 | |
| DOI |
10.1158/1557-3265.sabcs25-ps4-06-17
doi
|
| 其它 |
期刊:Clinical Cancer Research 作者:Y. Yin; A. Spira; H. Lan; M. Zhao; Y. Mao; et al 出版日期:2026-02-17 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)